1. P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS. (23rd June 2022) Authors: Duarte, D.; Duarte, S.; Sol dos Reis, C.; Silva Coelho, P.; Leite, L.; Branca, R.; Roncon, S.; Pinho Vaz, C.; Campos, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗